Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2670471000168114 | magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg + pyridoxine hydrochloride 4.25 mg + zinc amino acid chelate 50 mg capsule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2670481000168112 | zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | Is a | zinc + magnesium + pyridoxine | true | Inferred relationship | Some | ||
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 2016142747 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has Australian BoSS | pyridoxine hydrochloride | true | Inferred relationship | Some | 2016142746 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has intended active ingredient | pyridoxine | true | Inferred relationship | Some | 2016142746 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has Australian BoSS | magnesium oxide heavy | true | Inferred relationship | Some | 1879794478 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has intended active ingredient | magnesium | true | Inferred relationship | Some | 1879794478 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has Australian BoSS | magnesium aspartate tetrahydrate | true | Inferred relationship | Some | 673365749 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has intended active ingredient | magnesium | true | Inferred relationship | Some | 673365749 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has intended active ingredient | zinc | true | Inferred relationship | Some | 959252415 | |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has Australian BoSS | zinc amino acid chelate | true | Inferred relationship | Some | 959252415 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule, 90 | has MPUU | True | zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | Inferred relationship | Some | 1 |
| Zinc Magnesium Performance (Bioglan) (magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg + pyridoxine hydrochloride 4.25 mg + zinc amino acid chelate 50 mg) capsule (trade product unit of use) | Is a | True | zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set
FHIR